Laura L. Michel
-
- Breast Cancer Treatment Studies 15
- Cancer Genomics and Diagnostics 6
-
- Cancer Cells and Metastasis 7
- Cancer Treatment and Pharmacology 5
- Cancer Risks and Factors 4
-
- Advanced Breast Cancer Therapies 5
- Brain Metastases and Treatment 3
-
- Breast Lesions and Carcinomas 7
- Co-authors
- Andreas SchneeweißKatharina SmetanayAlexandra von AuFlorian SchützFrederik MarméAhmad I. AlomariThomas M. DeutschManuel Feißt
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Laura L. Michel
35 papers receiving 191 citations
Peers
Comparison fields: 5 of 48
- Cancer Research 72
- Oncology 120
- Pulmonary and Respiratory Medicine 60
- Genetics 15
- Radiology, Nuclear Medicine and Imaging 21
Countries citing papers authored by Laura L. Michel
This map shows the geographic impact of Laura L. Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura L. Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura L. Michel more than expected).
Fields of papers citing papers by Laura L. Michel
This network shows the impact of papers produced by Laura L. Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura L. Michel. The network helps show where Laura L. Michel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laura L. Michel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 8 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 12 | |
| 11 | 2021 | 2 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 25 | |
| 14 | 2020 | 3 | |
| 15 | 2019 | 4 | |
| 16 | 2017 | 3 | |
| 17 | T-DM1 as a New Treatment Option for Patients with Metastatic HER2-positive Breast Cancer in Clinical Practice. | 2015 | 8 |
| 18 | 2008 | 10 | |
| 19 | 2005 | 1 | |
| 20 | 1996 | 7 |
About Laura L. Michel
Laura L. Michel is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 37 papers that have together received 194 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), Cancer Cells and Metastasis (7 papers), Breast Lesions and Carcinomas (7 papers), Cancer Genomics and Diagnostics (6 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Risks and Factors (4 papers) and Brain Metastases and Treatment (3 papers). The work is most often cited by research in Cancer Research (72 citations), Oncology (120 citations) and Pulmonary and Respiratory Medicine (60 citations). Laura L. Michel has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Andreas Schneeweiß, Katharina Smetanay, Alexandra von Au, Florian Schütz, Frederik Marmé, Ahmad I. Alomari, Thomas M. Deutsch, Manuel Feißt, Markus Wallwiener and Fabian Riedel. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.